Skip to main content

Advertisement

Table 1 Antiretroviral drugs approved by the US Food and Drug Administration

From: 25 years of HIV-1 research – progress and perspectives

Nucleoside reverse transcriptase inhibitor Non-nucleoside reverse transcriptase inhibitor Protease inhibitor Entry inhibitor
Zidovudine Nevirapine Saquinavir Maraviroc
Didanosine Delavirdine Ritonavir  
Zalcitabine Efavirenz Indinavir Integrase inhibitor
Stavudine Etravirine Nelfinavir Raltegravir
Lamivudine   Atazanavir  
Abacavir   Fosamprenavir Combinations
Tenofovir   Tipranavir Six available, combining two or three drugs
Emtricitabine   Darunavir  
    Fusion inhibitor
    Enfuvirtide (T-20)
  1. Entry and fusion inhibitors prevent HIV-1 infection of cells; integrase inhibitor prevents integration of provirus into cellular chromosome.